Literature DB >> 29789721

Is leptin resistance the cause or the consequence of diet-induced obesity?

Kathy C G de Git1, Céline Peterse1, Sanne Beerens1, Mieneke C M Luijendijk1, Geoffrey van der Plasse1, Susanne E la Fleur2, Roger A H Adan3,4.   

Abstract

BACKGROUND/
OBJECTIVES: Obesity is strongly associated with leptin resistance. It is unclear whether leptin resistance results from the (over)consumption of energy-dense diets or if reduced leptin sensitivity is also a pre-existing factor in rodent models of diet-induced obesity (DIO). We here tested whether leptin sensitivity on a chow diet predicts subsequent weight gain and leptin sensitivity on a free choice high-fat high-sucrose (fcHFHS) diet.
METHODS: Based upon individual leptin sensitivity on chow diet, rats were grouped in leptin sensitive (LS, n = 22) and leptin resistant (LR, n = 19) rats (P = 0.000), and the development of DIO on a fcHFHS diet was compared. The time-course of leptin sensitivity was measured over weeks in individual rats.
RESULTS: Both on a chow and a fcHFHS diet, high variability in leptin sensitivity was observed between rats, but not over time per individual rat. Exposure to the fcHFHS diet revealed that LR rats were more prone to develop DIO (P = 0.013), which was independent of caloric intake (p ≥ 0.320) and the development of diet-induced leptin resistance (P = 0.769). Reduced leptin sensitivity in LR compared with LS rats before fcHFHS diet exposure, was associated with reduced leptin-induced phosphorylated signal transducer and activator of transcription 3 (pSTAT3) levels in the dorsomedial and ventromedial hypothalamus (P ≤ 0.049), but not the arcuate nucleus (P = 0.558).
CONCLUSIONS: A pre-existing reduction in leptin sensitivity determines the susceptibility to develop excessive DIO after fcHFHS diet exposure. Rats with a pre-existing reduction in leptin sensitivity develop excessive DIO without eating more calories or altering their leptin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29789721     DOI: 10.1038/s41366-018-0111-4

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  13 in total

1.  Orexin A-induced inhibition of leptin expression and secretion in adipocytes reducing plasma leptin levels and hypothalamic leptin resistance.

Authors:  Su-Kyung Shin; Seung-Eun Song; Jin Uk Oh; Meeyul Hwang; Hyun-Woo Cho; Jae-Hoon Bae; Seung-Soon Im; Jee-In Kim; Dae-Kyu Song
Journal:  Pflugers Arch       Date:  2019-10-30       Impact factor: 3.657

Review 2.  Review: Obesity and COVID-19: A Detrimental Intersection.

Authors:  Maria Alessandra Gammone; Nicolantonio D'Orazio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-30       Impact factor: 5.555

3.  Individual Differences in Behavioral Responses to Palatable Food or to Cholecystokinin Predict Subsequent Diet-Induced Obesity.

Authors:  Hallie S Wald; Harvey J Grill
Journal:  Obesity (Silver Spring)       Date:  2019-04-18       Impact factor: 5.002

Review 4.  Stressing the importance of choice: Validity of a preclinical free-choice high-caloric diet paradigm to model behavioural, physiological and molecular adaptations during human diet-induced obesity and metabolic dysfunction.

Authors:  Margo Slomp; Evita Belegri; Aurea S Blancas-Velazquez; Charlene Diepenbroek; Leslie Eggels; Myrtille C R Gumbs; Anil Joshi; Laura L Koekkoek; Khalid Lamuadni; Muzeyyen Ugur; Unga A Unmehopa; Susanne E la Fleur; Joram D Mul
Journal:  J Neuroendocrinol       Date:  2019-04-24       Impact factor: 3.627

5.  Rats that are predisposed to excessive obesity show reduced (leptin-induced) thermoregulation even in the preobese state.

Authors:  Kathy C G de Git; Johannes A den Outer; Inge G Wolterink-Donselaar; Mieneke C M Luijendijk; Erik Schéle; Suzanne L Dickson; Roger A H Adan
Journal:  Physiol Rep       Date:  2019-07

6.  Efficacy of choline and DHA supplements or enriched environment exposure during early adult obesity in mitigating its adverse impact through aging in rats.

Authors:  Gayathri S Prabhu; Keerthana Prasad; Mohandas Rao K G; Kiranmai S Rai
Journal:  Saudi J Biol Sci       Date:  2021-02-04       Impact factor: 4.219

7.  A targeted proteomics investigation of the obesity paradox in venous thromboembolism.

Authors:  Vincent Ten Cate; Thomas Koeck; Jürgen Prochaska; Andreas Schulz; Marina Panova-Noeva; Steffen Rapp; Lisa Eggebrecht; Michael Lenz; Julia Glunz; Madeleine Sauer; Raff Ewert; Michael Halank; Thomas Münzel; Stefan Heitmeier; Miguel A Andrade-Navarro; Karl J Lackner; Stavros V Konstantinides; Kirsten Leineweber; Philipp S Wild
Journal:  Blood Adv       Date:  2021-07-27

Review 8.  Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target.

Authors:  Eulla Keimili Fernandes Ferreira Cavalheiro; Ana Beatriz Costa; Daniéle Hendler Salla; Mariella Reinol da Silva; Talita Farias Mendes; Larissa Espindola da Silva; Cristini da Rosa Turatti; Rafael Mariano de Bitencourt; Gislaine Tezza Rezin
Journal:  Cannabis Cannabinoid Res       Date:  2021-07-09

Review 9.  Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions.

Authors:  Pamela Senesi; Livio Luzi; Ileana Terruzzi
Journal:  Int J Mol Sci       Date:  2020-11-08       Impact factor: 5.923

Review 10.  COVID-19 and Obesity: Overlapping of Two Pandemics.

Authors:  Maria Alessandra Gammone; Nicolantonio D'Orazio
Journal:  Obes Facts       Date:  2021-09-24       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.